BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11386514)

  • 1. Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
    Lu HR; Remeysen P; Somers K; Saels A; De Clerck F
    J Cardiovasc Electrophysiol; 2001 May; 12(5):538-45. PubMed ID: 11386514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT and JT dispersion in the drug-induced long QT syndrome in anaesthetized rabbits is accurately detected by a three-lead surface ECG measurement.
    Lu HR; Van Ammel K; Vlaminckx E; De Clerck F
    J Pharmacol Toxicol Methods; 2004; 49(2):71-9. PubMed ID: 14990331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
    Lu HR; Remeysen P; De Clerck F
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L; Andersson B; Linhardt G; Löfberg L
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):82-9. PubMed ID: 19528812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
    Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
    Limprasutr V; Saengklub N; Meedech P; Kijtawornrat A; Hamlin RL
    J Toxicol Sci; 2017; 42(5):579-587. PubMed ID: 28904293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.
    Qiu B; Wang Y; Li C; Guo H; Xu Y
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
    Lande G; Maison-Blanche P; Fayn J; Ghadanfar M; Coumel P; Funck-Brentano C
    Clin Pharmacol Ther; 1998 Sep; 64(3):312-21. PubMed ID: 9757155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sodium in contrast medium-induced polymorphic ventricular tachycardia: results in a rabbit model of lengthened QT interval.
    Idée JM; Bourgoin-Balut C; Lefevre T; Zamia P; Goulas V; Gaillard S; Mathias C; Bonnemain B
    Acad Radiol; 1998 Jun; 5(6):435-43. PubMed ID: 9615154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
    De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
    Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
    Boriani G; Biffi M; De Simone N; Bacchi L; Martignani C; Bitonti F; Zannoli R; Butrous G; Branzi A
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1935-8. PubMed ID: 11139961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.
    Inaba H; Hayami N; Ajiki K; Kunishima T; Watanabe H; Tsutsui K; Yamagishi N; Yamagishi S; Sugiura A; Mikamo T; Murakawa Y
    Circ J; 2011; 75(1):89-93. PubMed ID: 21139251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.